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Human epidermal keratinocytes possess cholinergic 
enzymes, which synthesize and degrade acetylcho­
line, and express both nicotinic and muscarinic 
classes of cholinergic receptors on their cell surfaces. 
These receptors bind acetylcholine and initiate cel­
lular response. The presence in keratinocytes of a 
functional cholinergic system suggests a role for 
acetylcholine in most, if not all, aspects of keratino­
cyte function. Autocrine and paracrine acetylcholine 
are required to sustain the viability of keratinocytes 
in vitro, and cholinergic drugs can alter keratinocyte 
proliferation, adhesion, migration, and differentia­
tion. Acetylcholine employs calcium as a mediator 
for its effects on keratinocytes. In turn, changes in 
A cetylcholine (ACh) is composed of a molecule of choline and an acetyl functional group con ected by an ester linkage. The synthesizing enzyme, choline acetyltransferase (ChAT), catalyzes the biosynthesis of ACh from acetyl coenzyme A and choline. The 
degrading enzyme, acetylcholinesterase (AChE), hydrolyzes ACh 
ta acetate and choline. 
ACh does not readily cross lipid membranes because of its highly 
palar, positively charged ammonium group. For this reason, ACh 
and its congeners initiate their biologic effects within cells by 
activating two different classes of cholinergic cell surface receptors, 
the nicotinic acetylcholine receptors (nAChRs) and the muscarinic 
acetylcholine receptors (mAChRs). The nAChRs are representa­
tives of a large superfamily of ligand-gated ion channel proteins 
(ionotropic receptors) formed by various combinations of trans­
membrane a, (3, )" 0, and E glycoprotein subunits (reviewed by 
Galzi et ai, 1991). In contrast, the mAChRs are single subunit 
transmembrane glycoproteins coupled to G-proteins. There are 
several molecular subtypes of these "metabotropic" receptors, 
named from m1 to mS mAChRs (reviewed by Hulme, 1990). The 
cholinergic nicotinic agonist nicotine and the muscarinic agonist 
muscarine selectively stimulate nAChRs and mAChRs, respec­
tively, thus reproducing the physiologic effects resulting from ACh 
binding to these cholinergic receptors. Likewise, the nicotinic 
antagonist mecamylamine and the muscarinic antagonist atropine 
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calcium concentration may affect expression and 
function of keratinocyte cholinergic enzymes and 
cholinergic receptors. At different stages of their 
differentiation, keratinocytes may demonstrate 
unique combinations of cholinergic enzymes and 
cholinergic receptor types. This would allow basal, 
prickle, and granular keratinocytes to respond to 
acetylcholine differently, in accordance with their 
functions at each stage of keratinocyte development 
in epidermis. Key words: acetylcholine synthesis and hy­
dl·olysislnicotinic and muscarinic receptol's and dl·ugsl kerati­
nocyte pl'olijeration, migration, adhesion, and diffel·entia­
tion. ]0 U1'1ta I of Investigative Del'lnatology Symposium 
PI'oceedings 2:41-48, 1997 
also bind to their respective receptors, but in a way that blocks ACh 
effects. 
ACh is best known for its role in neurotransmission but, increas­
ingly, a wider role for the cholinergic system in other aspects of cell 
functions is being recognized. This review summarizes recent 
findings regarding the biologically active but previously unrecog­
nized nonneuronal role of ACh for keratinocyte signal transduc­
tion. The keratinocyte cholinergic system includes: (i) ACh as a 
cytotransmitter; (ii) two cholinergic enzymes, ChAT and AChE, 
regulating ACh levels; and (iii) two classes of cholinergic receptors, 
nAChRs, and mAChRs, mediating ACh effects on cells. ACh and 
cholinergic drugs exhibit a plethora of effects on keratinocyte vital 
functions i11 lIitro, including viability, proliferation, adhesion, loco­
motion, and differentiation. Keratinocyte ACh, just like neuronal 
ACh, uses Ca2 + as a second messenger. In turn, changes in Ca2 + 
concentrations alter expression/function of keratinocyte cholin­
ergic enzymes and receptors. 
CHOLINERGIC ENZYMES ARE PRESENT IN 
KERATINOCYTES AND CONTROL ACETYLCHOLINE 
LEVELS IN THE EPIDERMIS 
Epidermal keratinocytes are among numerous types of prokaryote 
and eukaryote cells that can synthesize, store, release, and degrade 
ACh (reviewed by Grando and Horton, 1997). 
ChAT In cryostat sections of normal human skin pre-incubated 
with specifiC monoclonal antibodies and then stained with an 
avidin-biotin complex/alkaline phosphatase, ChAT is found 
throughout the surface epidermis and within the epidermal adnexae 
(Grando ef aI, 1993b). By indirect immunofluorescence, ChAT-like 
immunoreactivity occurs predominantly in the supra basal layers of 
epidermis, but immunoreactive cells are also seen in hair follicles, 
sweat gland ducts, and sebaceous ducts Oohansson and Wang, 
1993). In keratinocyte cultures, ChAT immunoreactivity is con-
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fined to the perinuclear area of keratinocyte cytoplasm, suggesting 
accumulation of this enzyme in the mitochondria (Grando et aI, 
1993b). 
The enzymatic activity (Vmax) of ChAT in keratinocyte homog­
enates, measured by both the conversion of [3Hlacetyl coenzyme A 
into [3H1ACh, and by the conversion ofrHlcholine into [3H1ACh, 
is approximately 20 /kM ACh/mg protein/min with an apparent 
Kill of 9 /kM (Gran do et ai, 1993b). These kinetic parameters of 
keratinocyte ChAT are well within the range reported for other 
nonneuronal, and neuronal cells (reviewed by Haubrich, 1976). 
AChE In rodents, AChE immunoreactivity in the epidermis 
peaks at the prenatal stage (Umezu et aI, 1993). In adult human 
epidermis, immunohistochemical staining shows AChE immunore­
activity predominantly in the basal cells (Gran do et aI, 1993b). 
Perhaps, the basal epidermal layer stains most intensely because 
melanocytes also possess AChE (Iyengar, 1989). In keratinocyte 
cultures, AChE immunoreactivity is seen in or near cell membranes 
and appears to be associated with intercellular filament bundles. As 
determined using a standard spectrophotometric assay, the activity 
of keratinocyte AChE in keratinocyte homogenates is about 1.13 
U/mg protein (Grando et aI, 1993b). Keratinocytes can also secrete 
their AChE, as AChE activity is detectable in the supernatants of 
keratinocyte monolayers. A putative form of secretory AChE, 
accumulating in epidermis, may be encoded by alternative 3'­
terminal exons (Seidman et ai, 1995). 
Acetylcholine (ACh) Using thin layer chromatography, newly 
synthesized ACh can be demonstrated in both keratinocyte homog­
enates and culture supernatants, indicating tllat human keratino­
cytes not only synthesize ACh but also secrete this cytotransmitter 
(Gran do et ai, 1993b). The mean rates of ACh synthesis and release 
by a single keratinocyte at 37°C are estimated to be 2 X 10-17 
mol/min and 7 X 10-19 mol/min, respectively. 
ACh metabolism in the skin may be altered in diseased states 
(Scott, 1962). At present, it is not known whether, or how, the 
balance of keratinocyte ACh synthesis and hydrolysis is altered in 
specific dermatologic conditions, but the importance of ACh for 
the viability of keratinocytes is demonstrated by the fact that 
depriving cultured keratinocytes of endogenous ACh by inhibiting 
keratinocyte ChAT with bromoacetylcholine kills cells (Grando et 
aI, 1993a). Microorganisms such as Psel.ldomollas aentginosa may also 
decrease ACh levels in the epidermis because their cholinesterases 
break down ACh in order to obtain free choline, which is a 
preferred substrate for their growtll and pathogenicity (Lisa et aI, 
1994). An exciting but unexplored area of research in this area 
concerns putative interrelationships between increased AChE lev­
els, decreased ACh, and the development of skin damage in 
extensive bums (Tomera and Lilford, 1995) and dystrophic epider­
molysis bullosa (Drugan et ai, 1995). 
NICOTINIC AND MUSCARINIC RECEPTORS MEDIATE 
THE EFFECTS OF ACETYLCHOLINE AND CHOLINERGIC 
DRUGS ON KERATINOCYTE FUNCTIONS 
Various neuronal and nonneuronal cells capable of synthesizing and 
secreting ACh may use this cytotransmitter for self-regulation of: (i) 
mitotic activity (Ashkenazi et aI, 1989); (ii) organization of the cell 
membrane skeleton (Bloch et aI, 1989); (iii) cell-substrate attach­
ment (Pumplin and Bloch, 1990); and (iv) cell movement (Sastry et 
aI, 1981). The elfects of ACh are mediated by two dilferent classes 
of cholinergic receptors, i.e., mAChRs and nAChRs, which coexist 
on the cell membranes of neuronal (Bencherif and Lukas, 1993), 
and nonneuronal cells such as lymphocytes (Richman and Arnason, 
1979; Bering et aI, 1987) and spermatozoa (Stewart and Forrester, 
1978; Young and Laing, 1991). Early studies showed that kerati­
nocytes are also among those nonneuronal cells that can bind 
cholinergic drugs and respond to them by changes in cellular 
function (Birnbaum et aI, 1976; Cuthbert and Wilson, 1981; 
Perchellet et ai, 1982; Carruthers and Neilson, 1983). These 
observations suggested that keratinocytes might express cholinergic 
receptors on their cell surfaces. More recent studies, employing a 
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combination of pharmacologic, electrophysiologic, immunologic, 
and molecular biologic approaches, showed that human keratino­
cytes express classical nAChRs and mAChRs as well as a novel 
cholinergic receptor containing the a9 subunit and demonstrating 
mixed nicotinic and muscarinic pharmacologic characteristics. 
Nicotinic Receptors (nAChRs) 
Keratinocytes Express Selleral Nicotinic Receptor Subullits The level of 
nAChR expression in keratinocytes can be detem1ined by the 
binding of radiolabeled ligands, such as nicotine and K-bungaro­
toxin (K-BTX). Radioligand-binding experiments utilizing C251_ 
K1BTX show that undilferentiated cultured keratinocytes have 
approximately 5,500 nAChRs/cell, whereas mature keratinocytes, 
freshly isolated from human epidermis, express approximately 
35,400 nAChRs/cell (Grando et ai, 1995a). Patch clamping exper­
iments demonstrate that nAChRs expressed on keratinocyte cell 
surfaces are indeed functional ion channels that mediate ion 
transport across the cell membranes. In outside-out patches excised 
from mature human keratinocytes, patch-clamp experiments reveal 
ACh-activated single-channel currents with a predominant conduc­
tance state of 32 pS. Single-channel currents with the same 
properties as those activated by ACh can be elicited by (+)­
anatoxin-a, which is a specific and selective nicotinic agonist 
(Thomas et ai, 1993). Single channels activated by ACh can be 
blocked reversibly or irreversibly by mecamylamine or K-BTX, 
respectively (Grando et aI, 1995a). This is in agreement with the 
mode of binding of these nicotinic antagonists to nAChRs. 
Polymerase chain reaction experiments utilizing human kerati­
nocyte cDNA demonstrate that keratinocytes express classic a3, 
as, a6,1 a7, {311, {32, and {34 nAChR subunits (Grando et aI, 1995a, 
1996). The ion channels formed by various combinations of these 
subunits were originally believed to be expressed exclusively by 
neuronal cells and were therefore called "neuronal," or "ganglion­
ic" nAChRs. The dilferences in subunit composition of these 
nAChRs determine the functional and pharmacologic characteris­
tics of the ion channels formed (reviewed by Conti-Tronconi et aI, 
1994). 
On the cell surfaces of cultured keratinocytes, the nAChRs can 
be visualized using antibodies to the receptor subunits (Grando et aI, 
1995a). When antibodies to the a3, {32, and /34 subunits are used, 
the middle and upper epidermal layers stain brightly whereas the 
basal layer does not stain at all. When anti-aS antibody is used, all 
epidermal layers stain evenly. Apparently, not only the number but 
also the subunit composition of nAChRs change as keratinocytes 
undergo dilferentiation. 
Nicotinic Pathways Maintain KeratillOcyte Viability and Ellhance Differ­
entiation Ion channels, such as nAChRs, play a crucial role in 
maintenance of cell viability (Mulle et aI, 1992). The nAChR 
channels mediate the influx of Na + and Ca2+ and efflux of K+. 
Experiments using muscarinic and nicotinic blocking agents dem­
onstrate that the interruption of nicotinic, but not muscarinic, 
pathways of ACh signaling inhibits keratinocyte division and results 
in premature cell death (Grando et ai, 1993a). This suggests that ion 
fluxes mediated by nAChR channels are essential for maintaining 
keratinocyte viability. 
S/lOrt-term exposure to nicotine stimulates cytoplasm motility 
and lateral migration of cultured keratinocytes (Grando et ai, 
199 Sa). Specifically, such nicotine exposure increases the speed of 
keratinocyte locomotion from approximately 1.5 /km to approxi­
mately 4.5 /km/min. Other functions, such as keratinocyte prolif­
eration, adhesion, and dilferentiation, may also be alfected by 
short-term exposure due to accelerated ion exchange through 
nicotinic channels. This may partially explain why nicotine-treated 
laboratory animals with dry-ice blisters show more rapid wound 
healing than untreated controls (Westerman et ai, 1993). 
1 Horton RM, Nguyen VT, Grando SA: A survey of cholinergic receptor 
types expressed in cultured human keratinocytes. ] Invest Derl1latol 108:603, 
1997 (abstr). 
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Chrollic exposure to nicotine abolishes migration of cultured 
human keratinocytes in a dose-dependent manner. 2 In contrast to 
ACh, nicotine is not degraded by AChE and therefore can remain 
pharmacologically active in culture medium for a longer time. 
Incubation with nicotine for several days results in more rapid 
keratinocyte differentiation. After 6 d of incubation, the nicotine­
treated cultures demonstrate significantly (p < 0.05) more cells 
with a suprabasal keratin phenotype and significantly (p < 0.05) 
more cells fornling cornified envelopes than nonexposed controls 
(Grando et ai, 1996). These findings confirm similar observations by 
Theilig et al (1994). Likewise, when incubated with nicotine for 2 
wk, the number of cells expressing keratinocyte differentiation 
markers such as transglutaminase, involucrin, and filaggrin exceeds 
that found in control, nonexposed cultures (Grando ct al, 1996). 
When mecamylamine, a nicotinic antagonist, is added to cultures 
along with nicotine, it blocks or attenuates the stimulatory effect of 
nicotine on keratinocyte differentiation rate. Taken together, these 
experimental data help explain delayed wound healing in tobacco 
users (reviewed by Sherwin and Gastwirth, 1990; Silverstein, 
1992). 
Muscarinic Receptors (mAChRs) 
Keratillocl'les Express Sell1'ral SlIbtypes of lHlIscarinic Receptors The 
muscarinic sites on mouse keratinocytes were originally identified 
using the radioligand CH]ACh and atropine as a nonlabeled 
competitor (Perchellet 1'1 ai, 1982). More recently, human kerati­
nocytes have been shown to express a heterogeneous population of 
high-density and high-affinity mAChRs (Grando et ai, 1995b; 
Grando and Horton, 1997). Using the nonselective reversible 
muscarinic radioligand r.1H]quinuclidinyl benzilate, the ligand 
binding capacity [binding maximum(BmaJ] of the mAChRs ex­
pressed by freshly isolated foreskin keratinocytes is found to be 
about 8.3 nmo1l2 X 10" cells, and the Kd of this ligand is about 21.5 
nM. As determined fi'om the conversion of the obtained Bmax value 
into absolute numbers of receptors per cell, each keratinocyte 
expresses approximately 2.4 X 10' mAChRs. This corresponds 
almost exactly to the number of mAChRs found on the cell surfaces 
of cultured keratinocytes using another muscarinic radioligand, 
r"Hjatropine (Grando and Dahl, 1993). Other tissue cells, such as 
tihroblasts and acinar cells of exocrine glands, also express 
mAChRs in a high density of 2 X 10' (Andre et ai, 1988) and 2.5 X 
10' (Hootman el ai, 1985) receptors/cell, respectively, whereas 
lymphocytes have a lower density of about 6 X 10' receptors/cell 
(Bering 1't aI, ] 987). 
The anti-mAChR monoclonal antibody M35 (Andre et ai, 1984) 
specifically stains human epidermal keratinocytes in experiments 
using both indirect immunofluorescence and immunoelectron mi­
croscopy (Gran do et ai, 199 5b). In the intact epidermis, M35 
binding produces an intercellular staining pattern, which is densest 
at the level of the basal cells, but less staining is also found at the 
spinous and granular cell layer. The dead cells of the stratum 
corneum are unstained. In the upper dermis, M35 stains fibroblasts, 
which is expected because it labels the fibroblast-type mAChRs 
(Raposo 1'1 ai, 1987). The M35 antibody also stains cultured 
kcratinocytes.' The surface staining pattern changes from homog­
enous to intercellular as the cells differentiate in response to 
increasing concentrations of Ca2+ in the growth medium. 
At the electron microscopic level, keratinocyte mAChRs are 
found on the cell membrane, specifically in association with 
desmosomes (Grando el ai, 1995b). The presence of mAChRs at 
these sites of cell-to-cell contact would be especially appropriate if 
these receptors foster intercellular communications between epi­
dennal cells. 
, Lee TX, Horton RM, Grando SA: Cholinergic drugs stimulate chemo­
kinesis of human epidermal keratinocytes. ] [""cst Dermato! 106:841. 1996 
(abstr). 
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There are at least five molecular subtypes (ml, m2, m3, m4, and 
m5) and three pharmacologic subtypes (Ml, M2, and M3) of 
mAChRs. The pharmacologic subtypes correlate closely with the 
molecular subtypes. The molecular mass (Me) of m 1, m2, and m4 
mAChR subtypes is about 66 kDa, whereas that of m3, and m5 is 
about 92 kDa (McLeskey and Wojcik, 1990). The receptor proteins 
can be covalently labeled with irreversible muscarinic antagonist 
[-'H]propylbenzilylcholine mustard (PrBCM) or visualized in 
Western blots by M35 antibody (Grando el ai, 1995b). Two 
separate peaks of radioactivity with approximate M,. values of 60 
and 95 kDa are seen in ['H]PrBCM-labeled keratinocyte mem­
brane proteins resolved by sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis. In Western blots, the M35 antibody visualizes 
a double band at approximately 60 kDa and a single band at 
approximately 95 kDa. The apparent isoelectric point of receptor 
proteins is at pH 4.3, as determined in Western blots of isoelectric 
focusing gels using the M35 antibody. 
More recently, using oligonucleotide primers that match se­
quences of known mAChRs, we performed polymerase chain 
I'eaction of intronless sequences in which the contamination by 
genomic DNA was controlled by treating cellular nucleic acids with 
DNase. With tllls technique we demonstrated the presence of 
classic m1, m2, m3, m4, and m5 mAChR subtypes in human 
keratinocytes. I 
The ml, mJ, and m5 mAChR subtypes selectively bind to a 
putative pertussis toxin-insensitive G-protein to stimulate phospho­
lipase C. TillS causes the release of both phosphatidylinositol, which 
releases Ca2+ from intracellular stores, and diaglycerol, which 
activates protein kinases. These odd-numbered mACIlR subtypes 
also stimulate arachidonic acid release and cAMP production and 
open Ca2+ -dependent K+ channels. The mAChR subtypes, m2 
and m4, selectively couple a putative pertussis toxin-sensitive 
G-protein to inlllbit previously stimulated adenylyl cyclase and also 
open K + channels (reviewed by Caulfield, 1993). 
An m5 mAChR is also found in an early passage human 
melanoma cell line (Kohn el ai, 1996). This study showed that, in 
contrast to the odd mAChR pattern, the m5 mAChR expressed by 
melanocytes could both stimulate phospholipase and inhibit adeny­
Iyl cyclase. Alternatively, melanocytes might express an even­
numbered mAChR subtype as well. 
JI;[uscarillic Pathlllays COlltrol K1'ralil1ocyle Pro I iferatio 11 alltl Enhal1ce 
lvIigralioll In order to clarify the role of mAChRs in keratinocyte 
biology, we used an ill IJitro technique we have termed the agarose 
gel keratinocyte outgrowth system (AGKOS) (Grando 1't ai, 1993a). 
AGKOS proved to be a reliable and highly specific ill IIitl'O 
technique for investigating keratinocyte outgrowth as determined 
by cell-matrix attachment, spreading, and locomotion. As shown 
by the AGKOS teclmique, long-term stinlUlation of keratinocyte 
mAChRs with muscarine significantly (p < 0.05) increases kerati­
nocyte migration distance in a dose-dependent maimer." On the 
other hand, and as expected, use of the irreversible muscarinic 
antagonist PrBCM considerably diminishes keratinocyte outgrowth 
in AGKOS. In this model, exogenously added ACh fails to restore 
outgrowth because keratinocyte mAChRs are irreversibly bound 
with PrBCM. 
To clarify how mACIlRs control keratinocyte outgrowth under 
agarose, we measured the direct effects of muscarinic drugs on four 
attributes of keratinocyte function: proliferation, viability, cell­
matrix (plastic) attachment, and spreading (Grando 1't ai, 1993a). 
ACh (as well as the muscarinic agonists methacholine and bethane­
chol) stimulated spreading of keratinocyte cytoplasm, cell-substrate 
attachment, crawling-type locomotion, and formation of intercel­
lular junctions. Conversely, the use of the mllScatinic antagonist 
PrBCM inhibited keratinocyte cell-plastic attachment, spreading, 
and migration. Rather unexpectedly, however, PrBCM also stil1l-
< Lee TX, Horton KM, Granda SA: Cholinergic drugs stimulate chemo­
kinesis of human epidermal keratinocytes. ] I,west Dermata! 106:841, 1996 
(abstl'). 
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ulated keratinocyte proliferation. The number of cells exposed to 
PrBCM doubled after 24 h of incubation and almost tripled after 
48 h. Since PrBCM-induced proliferation of cultured keratinocytes 
did not increase keratinocyte outgrowth in AGKOS, cell migration, 
rather then proliferation, is apparently responsible for keratinocyte 
outgrowth in the AGKOS plates. 
The stimulatory effect of PrBCM on keratinocyte proliferation 
may be related to the inactivation of signal transduction pathways 
controlled by keratinocyte ml, m3, or m5 mAChRs because a 
pertussis toxin-insensitive G-protein- coupled mAChR can inhibit 
cell proliferation (Williams and Lennon, 1991). Activation of m5 
mAChR, for example, reduces c1onogenic potential of human 
melanoma cells (Kohn et ai, 1996). 
Chronic blockade of keratinocyte mAChRs with another mus­
carinic antagonist, scopolamine, results in maintenance of an 
immature phenotype when keratinocytes are incubated with agents 
that usually cause differentiation.' Because PrBCM and scopol­
amine interrupt constant physiologic stimulation of keratinocyte 
mAChRs with endogenous ACh, the muscarinic pathways of signal 
transduction in keratinocytes may be required to control ceJl 
proliferation. This would correlate with the fact that the bulk of 
mAChR immunoreactivity is present at the basal and immediate 
suprabasal epidermal layers, i.e., at the point where keratinocytes 
undergo all of their proliferative activity. 
Mixed Nicotinic-and-Muscarinic Receptors 
Nicotil1ic al1d Muscarinic Pathways Stimulate Keratinocyte Adhesiol1 ill a 
Similar Fashioll The results of the studies described above suggest 
a reciprocal regulatory pattern of keratinocyte functions by endog­
enous ACh. Functions elicited via the nicotinic pathway of ACh 
signaling (such as proliferation and differentiation) arc inhibited via 
the muscarinic pathway. Vice versa, the function elicited via the 
muscarinic pathway (such as migration) is inhibited via the nicotinic 
pathway. In contrast, however, nicotinic and muscarinic drugs have 
a similar, rather than a reciprocal, effect on keratinocyte adhesion. 
For example, addition of millimolar concentrations of ACh to 
suspended keratinocytes results in rapid cell adherence to the 
bottom of the tissue culture dish. The keratinocytes settle, spread 
their cytoplasm, flatten, establish interceJlular contacts, and, within 
30 min, form a confluent monolayer, whereas in the absence of 
added ACh, this process takes approximately 2 h. Interestingly, this 
stimulatory effect of ACh on adhesion of keratinocytes to the 
substrate can be reproduced by both nicotinic agollists and musca­
rinic agonists (Grando et ai, 1993a, 1995a). Both nicotinic and 
muscarinic agonists can also preserve keratinocyte monolayers from 
the acantholytic effects of pemphigus antibody and can reverse 
cell-cell detachment produced by pemphigus antibody, by the 
serine proteinase trypsin, and by the calcium chelator ethylenedia­
mine tetraacetic acid (Grando and Dahl, 1993). 
The effects of nicotinic and muscarinic antagol1ists on keratinocyte 
adhesion are also similar. Both nicotinic (mecamylamine and 
K-BTX) and muscarinic (atropine and PrBCM) antagonists cause 
cell-cell detachment (acantholysis). The rate of cell separation in 
keratinocyte monolayers depends on the dose of drug, but the 
sequence of morphologic changes is always the same, regardless of 
whether nicotinic or muscarinic antagonists are used. As seen in Fig 
lA-D, within 3-5 min of addition of a millimolar concentration of 
either type antagonist, the cells of a confluent monolayer abruptly 
lose their polygonal shape (as if their cytoskeleton has suddenly 
coJlapsed), retract their cytoplasmic aprons to separate themselves 
from neighboring cells, internalize the remaining spindle-shaped 
cytoplasmic protrusions, and then initiate peripheral cytoplasmic 
blebbing that gives them a rosette-like appearance. In agreement 
with known cholinergic pharmacology, the changes induced by 
reversible antagonists, such as mecamylamine and atropine, reverse 
spontaneously, whereas the changes induced by irreversible an tag-
; Grando SA, lynch PJ: Muscarinic antagonist protects keratinocyte 
monolayers from morphologic transformations induced by enalapril, and 
thiol drugs . .l 1I1I'('.'t Del'll/atal 100:541, 1993 (abstr). 
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Figure 1. Atropine-induced reversible acantholysis. A confluent 
keratinocyte monolayer in six-well tissue culture plate before exposure (A), 
and 1 (B), 2 (C). 3 (D). 5 (E), 1 () (F). 211 (G), and 30 (H) min after addition 
of 1 mM atropine. Within 3 min after exposure, keratinocytes retract their 
intermediate filament bundles, become spherical in shape, and completely 
detach from eacb other but not from the dish. Within the next 20-25 min, 
these changes reverse spontaneonsly. The cells flatten and enlarge in size. 
Their cytoplasmic aprons rapidly spread and acqnire new intermediate 
filament bundles that link neighboring cells into confluent monolayer. 
Tbese pbase-contrast images were taken from the same microscopic field. 
Scale !>ar, 57 /-Lm. 
onists, such as K-BTX and PrBCM, are permanent. Within 30 min 
after washing out a reversible antagonist or adding an agonist, the 
cascade of antagonist-induced morphologic changes reverses. The 
keratinocytes flatten, and the blebs on the periphery of their 
cytoplasm evolve into cytoplasmic aprons that spread outward, 
giving the keratinocytes new polygonal shapes. The spreading of 
keratinocyte cytoplasm continues until the cell borders reach 
neighboring cells, after which keratinocytes re-form intercellular 
contacts and re-establish a confluent monolayer (Fig iE-H). 
The f.'1ct that both nicotinic and muscarinic drugs alter keratino­
cyte adhesion in the same way might be explained by either of the 
following hypothetical mechanisms. First, both nAChRs and 
mAChRs might utilize the same biochemical pathway, which 
regulates assembly and disassembly of the cytoskeleton and regu­
lates function of the adhesion units that mediate cell-to-substrate 
and cell-to-cell attachments. Indeed, in other cell types, classic 
nAChRs and mAChRs can be associated, physically or function­
ally, with adhesion molecules such as integrin (Bozyczko et ai, 
1989) and E-cadherin (Williams ct ai, 1993). 
Alternatively, or additionally. a single type of keratinocyte 
cholinergic receptor possessing mixed nicotinic-and-muscarinic 
pharmacology might be chiefly responsible for physiologic control 
of keratinocyte adhesion. 
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Humall Keratillocytes Express a Mixed Nicotillic-aHd-Nlllscarillic Cholin­
ergic Receptor The existence of a third category of cholinergic 
receptors with mixed nicotinic-and-muscarinic pharmacologic 
characteristics was originally suggested by experiments with bovine 
chromaffin cells (Shirvan et ai, 1991), nematode somatic muscle 
(Colquhoun et ai, 1991), and insect neurosecretory cells (Lapied et 
ai, 1990). Only recently, however, the first member of this category 
(termed the a9 nAChR subunit) has been cloned from rat brain 
(Elgoyhen et ai, 1994). This a9 subunit assembles into a homomeric 
ACh receptor-channel complex, which, although "nicotinic" by 
structural homology, responds to both nicotinic and muscarinic 
drugs. 
The presence of cholinergic receptor with mixed nicotinic and 
muscarinic characteristics in keratinocytes was first suggested by 
competitive binding of nicotinic and muscarinic drugs to tadpole 
epidermal cells (Cox, 1993). To identify the human 0'9 homolog in 
keratinocytes, we used degenerate polymerase chain reaction prim­
ers for the most conserved regions of the nAChR subunits. 
Sequencing of polymerase chain reaction products amplified from 
human keratinocyte cDNA revealed a clone that had a sequence 
>90% similar to rat 0'9.6 The possibility that this novel cholinergic 
receptor regulates keratinocyte adhesion is supported by our ob­
servations that strychnine, which blocks the rat 0'9 receptor (EI­
goyhen et ai, 1994), alters keratinocyte adhesion in the same way as 
nicotinic and muscarinic antagonists,7 The presence in human 
keratinocytes of both ACh receptor with mixed pharmacologic 
characteristics and classical nAChRs and mAChRs could help 
explain why certain nicotinic and muscarinic drugs can produce 
similar effects on keratinocyte adhesion, willie at the same time, 
producing opposite effects on other keratinocyte functions such as 
proliferation, migration, and differentiation. 
CALCIUM MEDIATES CHOLINERGIC EFFECTS ON 
KERA TINOCYTES 
Calcium, because of its role as a second messenger, plays a crucial 
role in regulating keratinocyte differentiation and in regulating 
various other cellular functions of keratinocytes (reviewed by 
Yuspa et ai, 1988; Fairley, 1989). ACh has been shown to modulate 
transmembrane transport and intracellular metabolism of Ca2 � in a 
variety of cell types (Gasic and Heinemann, 1992). To determine 
whether ACh controls Ca2+ flux in keratinocytes, 45Ca2+ influx 
and efflux were measured while cells were exposed to nicotinic or 
muscarinic drugs (Grando et ai, 1996; Grando and Horton, 1997). 
We showed that nicotine increases, in a concentration-dependent 
manner, the ilif/IIX of 45Ca2+ into differentiated keratinocytes 
freshly dissociated from human neonatal foreskins. This stimulatory 
effect becomes signitlcant (p < 0.05) at 1. 0 f.LM and higher 
concentrations of the drug. The specitlc nicotinic antagonist 
mecamylamine significantly (p < 0. 05) diminishes nicorine-evoked 
45Ca2+ uptake. This inhibitory effect of mecamylamine is concen­
tration-dependent. Nicotine also increases 45Ca2+ uptake by un­
differentiated keratinocytes cultured at 0.09 mM Ca2+, but the 
observed changes do not reach signitlcance compared to the 
baseline influx. This suggests that the nAChR-mediated Ca2+ 
influx pathway is more active in suprabasal keratinocytes than it is 
in undifferentiated basal cells. It is noteworthy that differentiated 
keratinocytes express more nAChR channels than undifferentiated 
cells (Grando et ai, 1995a). 
In differentiated keratinocytes, the nAChR containing a3 subunit 
may be the m<0or ligand-gated channel type that mediates Ca2+ 
influx because (i) in other cells, this type of ACh-gated cationic 
channel permits a substantial Cal + influx and has a conductance of 
6 Horton RM, Lee TX, Grando SA: Cloning of the human alpha-9 
AChR subunit from normal epidermis and investigations into its physiologic 
role. FASEBJ 10:A688, 1996 (abstr). 
7 Grando SA, Mauro T, Lee TX, Mirfakhraie K, Horton RM: Novel 
human 0'9 acetylcholine receptor subunit, and other new members of the 
epidennal acetylcholine receptor family. ] I,west Dermatol 106:834, 1996 
(abstr). 
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-30 pS (Fieber and Adams, 1991), which is similar to that of the 
ACh channel we measure by the patch clamp technique after 
cultured keratinocytes have been differentiated by increasing extra­
cellular Ca2+ from 0.09 to 1.6 mM; and (ii) the anti-0'3 nAChR 
subunit antibody selectively stains suprabasal keratinocytes, leaving 
the basal epidermal layer unstained (Grando et ai, 1995a). 
By analogy to neuronal cells, the Ca2+ influx elicited by nicotine 
in keratinocytes may be also mediated by other types of nAChR 
channels present in keratinocytes. For instance, the 0'5 subunit that 
can be detected in neuronal cells demonstrated Ca2+ conductance 
when exposed to nicotine (Didier et ai, 1995). Likewise, the 0'7 
subunit, which can form functional homomeric nAChRs, is highly 
permeable to Ca2+ (Bertrand et ai, 1993). Finally, the 0'9 nAChRs 
may participate in Ca2+ conductance because in rats this subunit 
can assemble into a homomeric ACh receptor-channel complex 
that mediates an inward Ca2+ current (Elgoyhen et ai, 1994). 
In mature keratinocytes, a substantial influx of 45Ca2+ is also 
elicited when cell membranes are depolarized. Depolarization can 
be achieved by switching the cells from low to high extracellular 
K+ concentrations. The nicotinic antagonist mecamylamine in­
hibits this K+ -elicited 45Ca2+ influx. Perhaps the depolarization­
dependent 45Ca2+ influx abolished by mecamylamine is mediated 
by keratinocyte nAChRs when these receptors are activated by 
ACh secreted in response to depolarization of cell membranes. This 
possibility is supported by the observation that depolarization can 
stimulate ACh secretion by neurons (reviewed by Silinsky, 1985) 
and by the observation that nAChR-dependent secretion of ACh is 
coupled to Ca2+ influx via voltage-gated Caz+ channels (Takahashi 
et ai, 1992). If this mechanism also exists in keratinocytes, it might 
provide a feedback stimulus for a sustained release of ACh by 
epidermal keratinocytes. 
As opposed to their positive effects on 4SCa2+ influx, the 
nicotinic agonists produce no significant changes in 45Ca2+ efflux 
from keratinocytes pre-loaded with radioactive calcium. Instead, 
calcium efflux appears to be controlled by mAChRs (Grando and 
Horton, 1997). Muscarine increases '''Ca2+ efflux, and this effect is 
dose-dependent and becomes signitlcant (p < 0.05), compared to 
control cells, at the 10 f.LM concentration of the agonist. 
Muscarine decreases 4SCa2 + influx into both mature and imma­
ture keratinocytes (Grando and Horton, 1997). Muscarine also 
partially inhibits the rise in intracellular Ca2+ induced by raising 
extracellular Ca2 + concentrations. 8 This inhibitory effect of mus­
carine may be due to activation of the m2 or m4 subtype of 
keratinocyte mAChRs, which can inhibit Ca2+ currents (reviewed 
byJones, 1993). 
In contrast, addition of muscarine to keratinocytes cultured at 
low, 0.07 mM, Ca2+ causes an increase in intracellular Ca2+, which 
is probably due to the release of Ca2+ from the intracellular stores 
due to activation of the keratinocyte m1, m3, or m5 mAChR 
subtypes coupling a pertussis toxin-insensitive G-protein to stimu­
late phospholipase C. This in turn releases phosphatidylinositol, 
which then releases Ca2+ from intracellular stores. 
Atropine, which competes with muscarine at keratinocyte 
mAChRs, abolishes the effects of muscarine on transmembrane 
Caz+ flux. Similar effects on Ca2+ influx and efflux in pancreatic 
B-cells can be elicited also by ACh and abolished by atropine (Gilon 
et ai, 1995). 
The observations above suggest that the muscarinic effects on 
transmembrane Ca2+ transport into keratinocytes are the opposite 
of the effects produced by nicotinic agents. Perhaps, under natural 
conditions, a stimulatory effect of ACh on Ca2+ influx into 
keratinocytes, mediated by its nicotinic action, is balanced by an 
inhibitory effect, mediated by its muscarinic action. 
8 Grando SA, Mauro T: Acetylcholine controls transmembrane calcium 
transport in human keratinocytes. ] Invest Dermatof 104:592, 1995 (abstr). 
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Figure 2. The relationships between epidermal distribution of 
keratinocyte cholinergic enzymes and Ca2+ gradient. The even 
distribution of the synthesizing enzyme ChAT throughout epidermal layers 
and the predominant localization of the degrading enzyme AChE to the 
basal epidermal layer might allow accumulation of free ACh in the upper 
epidermal compartments. The resultant concentration gradient of ACh 
wonld then coincide in direction with the upward concentration gradient of 
Ca2+ in epidermis. This may have biologic significance because ACh uses 
Ca2+ as a second messenger of its effects on keratinocytes. 
THE ACETYLCHOLINE-CALCIUM AXIS OF HUMAN 
EPIDERMIS 
By simultaneously activating nAChRs and mAChRs on the cell 
membrane of a single keratinocyte, ACh may balance Ca2+ me­
tabolism to synchronize various ionic and metabolic sequelae 
required to sustain keratinocyte development in epidermis. A 
physiologic upward gradient of Ca2+, which correlates with the 
level of keratinocyte differentiation, has been demonstrated in 
epidermis (Menon et aI, 1992, 1994). Within this gradient, the 
concentrations of both extra- and intracellular Ca2+ gradnally 
increase from basal to granular cell layers. Similarly, it can be 
postulated that the concentration of free ACh will be higher in the 
upper compared to lower epidermis because the synthesizing 
enzyme ChAT is present equally in the basal and suprabasal layers 
of the epidermis, whereas the degrading enzyme AChE is predom­
inant in basal keratinocytes (Fig 2). 
Increased extracellular or intracellular Ca2+ triggers keratinocyte 
differentiation (Boyce and Ham, 1983; Sharpe et aI, 1993). During 
Ca2+ -induced differentiation, cultured keratinocytes gradually lose 
their mAChR immunoreactivity and responsiveness to muscarinic 
drugs, but increase their nAChRs.9 In agreement with these 
observations made in keratinocyte culture, there is also a reciprocal 
distribution of the keratinocyte nAChRs and mAChRs in whole 
epidermal slices: immature, basal keratinocytes predominantly ex­
press mAChRs, whereas suprabasal epidermal layers exhibit the 
bulk of nAChR immunoreactivity. As noted earlier in this review, 
stimulation of keratinocyte nAChRs with nicotine accelerates the 
rate of cell differentiation, and tlJis phenomenon may be related to 
an increased Ca2+ influx. Because differentiated keratinocytes 
display more functional nAChRs, chronic stimulation of keratino­
cytes with nicotine appears to upregulate the expression of its own 
receptors by the cells. Such an upregulating phenomenon is also 
seen in neurons (Flores et aI, 1992). 
The metamorphosis of the keratinocyte cholinergic system dur­
ing the process of keratinocyte maturation in the epidermis creates 
a unique ratio of keratinocyte cholinergic receptors at each differ­
entiation stage. In our model, ACh is endogenously synthesized and 
9 Grando SA, Bigliardi PL, Zelickson BD, Dahl MV: Location and 
character of keratinocyte muscarinic receptors. ] [livest Dermato/ 101:397, 
1993 (abstr). 
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secreted by keratinocytes in the epidermis, but it produces differem 
biologic effects at different stages of cell differentiation by activating 
different types of keratinocyte cholinergic receptors. Each combi· 
nation of nicotinic and muscarinic cholinergic receptors provides 
control for specific cellular functions required for ongoing kerari· 
nocyte differentiation. Constant stimulation of keratinocytes via 
their nicotinic pathway might be the driving force for their growth 
and maturation because both inlJibition of ACh synthesis and 
blockage of keratinocyte nAChRs (but not mAChRs) stops kera· 
tinocyte division and kills the cells. In marked contrast, the role of 
mAChRs at the initial stage of keratinocyte development in 
epidermis may be to control mitosis so as to prevent excessive 
proliferation of basal cells and facilitate upward migration of 
daughter cells. Later on, at the suprabasal levels, the nicotinic 
pathway of signal transduction apparently takes over the physio­
logic control of keratinocyte differentiation and comification. 
Keratinocyte adhesion, an important function mediating integrity 
(cohesion) of the epidermis, is sustained in our ill vitro studies by 
ACh. Although it is not yet clear which class of keratinocyte ACh 
receptors might mediate ACh effects on keratinocyte adhesion, all 
cholinergic agonists foster formation of intercellular junctions by 
keratinocytes. It is therefore possible that within the lower and 
mid-epidermis, maintenance of desmosomal adhesion is an impor. 
tant function of epidermal ACh. 
Thus, by simultaneously activating different types of keratinocyte 
cholinergic receptors in the epidermis, ACh may produce a kind of 
a yin yang regulatory balance for keratinocyte cellular functions 
mediating tumover of the epidermis. In so doing, ACh may playa 
role of "pacemaker" for keratinocyte development in epidermis 
(Fig 3). 
CONCLUSION 
The fact that all components of a functional cholinergic system are 
present in human keratinocytes is not surprising given the ubi qui-
Figure 3. The hypothetical yin yang effect of ACh in epidermis, 
The presence of both mAChRs and nAChRs on a single keratinocyte, taken 
together with the notion that the biologic effects of these receptors are 
opposite, suggests a regulatory mechanism whereby the stimulatory and 
inhibitory effects of ACh on keratinocytes are balanced. Simultaneous 
activation of both receptors by ACh could elicit both ionic flows and 
metabolic cascades, maintaining viability of the cells and subserving their 
vital functions. Furthermore, the predominant localization of mAChRs to 
the basal cells and that of nAChRs to the suprabasal keratinocytes would 
allow ACh to regulate keratinocyte functions selectively, depending on the 
stage of their development in epidermis. For example, by activating 
mAChRs, ACh will control proliferation of basal cells, their adhesion to the 
basement membrane and neighboring cells, as well as upward migration of 
their daughter cells. At the same time, by stimulating nAChRs, ACh will 
facilitate formation of desmosomes by prickle cells and foster their terminal 
differentiation. Thus, the reciprocal regulatory pathways coupled by kera­
tinocyte mAChRs and nAChRs might be in effect complementary. This 
would allow keratinocyte ACh to function as a pacemaker, which may be a 
driving force of epidermal turnover. 
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tous presence of ACh and its nicotinic and muscarinic receptors in 
multiple other cell systems, Furthermore, based on the fact that 
ACh is a universal cytotransmitter regulating basic functions of 
prokaryotes and eukaryotes, it is not surprising that ACh and its 
congeners can regulate vital functions of human epidermal kerati­
nocytes in so many ways, The simple presence of the cholinergic 
system in keratinocytes certainly warrants investigation as to 
whether ACh metabolism and/or signaling are altered in skin 
diseases, and, on the other hand, whether cholinergic drugs may be 
useful adjuncts in dermatologic therapy. It will also be important to 
determine, however, whether functional cholinergic systems are 
present in other skin cells, such as melanocytes, fibroblasts, endo­
thelial cells, Langerhans cells, and Merkel cells, and whether ACh 
controls communications among these cells. 
It is even more important to investigate whether ACh mediates 
signaling between neurons and nonneuronal cells inhabiting skin. 
The presence in keratinocytes of ChAT and AChE that control 
ACh levels and the presence of ACh-gated ion channels that could 
mediate rapid signal transduction throughout the epidermis suggest 
that human keratinocytes are themselves receptor cells. By analogy 
to retinal epithelial cells that release ACh in response to light 
stimulus (Hutchins and Hollyfield, 1986), epidermal keratinocytes 
may convert environmental stimuli, such as temperature, UV light, 
atmospheric pressure, or humidity, into chemical signals such as 
ACh, This might occur via a mechanism wherein environmental 
factors acting upon the skin simply change the kinetics of the 
enzymes synthesizing and degrading ACh. Newly synthesized and 
released keratinocyte ACh might then evoke electrical responses in 
epidermal nerves, which then would allow rapid transduction of 
information from the epidermis to the central nervous system. The 
central nervous system, in turn, might then use its own ACh to 
signal its own messages back to the skin. 
I am grateji'l to Peter ]. Lynch, M.D., for his thorough examination of the 
manuscripts and extensive editing and for his constructive critique and helpful 
suggestions. This work was suppO/ied by National Institutes of Health Crant R29 
AR-42955 and a research grantji'Olt/ the Councilfor Tobacco Research-U.S.A., Inc. 
REFERENCES 
Andre C, Guillet JG, De Backer J-p. Vanderheyden P, Hoebeke J, Strosberg AD: 
Monoclonal antibodies against the native or denaturated forms of muscarinic 
acetylcholine receptors. EMBO] 3 :1 7-21 ,  1984 
Andre C, Marullo S, Convents A, Lu BZ, Guillet JG, Hoebeke J, Strosberg AD: A 
human embryonic lung fibroblast with a high density of muscarinic acetylcholine 
receptors. Ellr] Biochem 1 7 1  :401-407, 1988 
Ashkenazi A, Ramachandran J, Capon DJ: Acetylcholine analogue stimulates DNA 
synthesis in brain-derived cells via specific muscarinic receptor subtypes. Nature 
340:1 46-1 50, 1 989 
Bencherif M, Lukas RJ: Cytochalasin modulation of nicotinic cholinergic receptor 
expression and lnuscarinic receptor function in human TE671 /RD cells: a 
possible functional role of the cytoskeleton. ] Neurochem 61 :852-864, 1 993 
Bering B,  Moiscs HW, Muller WE: Muscarinic cholinergic receptors on intact human 
lymphocytes. Properties and subclass characterization. BioI PsychoI 22:1 4S1-1 458, 
1 987 
Bertrand D, Galzi JL, Devillers-Thiery A, Bertrand S, Changeux JP: Mutations at two 
distinct sites within the channel domain M2 alter calcium permeability of 
neuronal 017 nicotinic receptor. Proc Natl Acad Sci USA 90:6971-6975, 1 993 
Birnbaum JE, Sapp TM, Moore JB Jr: Effects of reserpine, epidermal growth factor, and 
cyclic nucleotide modulators on epidermal mitosis.) Invest Dermatol 66:313-3 1 8, 
1976 
Bloch H.J, Velez M, Krikorian JG, Axelrod 0: Microfilaments and actin-associated 
proteins at sites of nlembrane-substrate attachment within acetylcholine receptor 
clusters. Exp Cell Res 1 82:583-596, 1989 
Boyce ST. Ham RG: Calcium-regulated differentiation of normal human epidennal 
keratinocytes in chemically defined clonal culture and serum-free serial culture. 
] Invest DermatoI 8 1 (suppl l ) :33S-40S, 1 983 
Bozyczko D, Decker C, Horwitz AF: Integrin on developing and adult skeletal 
muscle. Exp Cell Res 183:72-91 ,  1 989 
Carruthers C, Neilson A: Eflcct of 1 2-0-tetradecanoyl-phorbol-1 3-acetate and 
3-methylcholanthrene on the toxicity of nicotine applied to mouse skin. Oncology 
40:404-409, 1 983 
Caulfield MP: Muscarinic receptors-characterization. coupling and function. Phanna­
col Thcr 58:3 1 9 -379, 1993 
KERATINOCYTE CHOLINERGIC SYSTEM 47 
Colquhoun L, Holden-Dye L, Walker HJ: The pharmacology of cholinoceptors on the 
somatic muscle cells of the parasitic nematode Ascaris suum . }  Exp BioI 1 S8 : 509-
530, 1 99 1  
Conti-Tronconi B M ,  McLane RE ,  Raftery M A ,  Grando S A ,  Protti MP: The nicotinic 
acetylcholine receptor: structure and autoimmune pathology. erit ReI' Bi{)chem 
Mol Bioi 29:69-123, 1994 
Cox TC: Low-affinity mixed acetylcholine-responsive receptors at the apical mem­
brane of frog tadpole skin. Am ] Physiol 264:C552-558, 1 993 
Cuthbert A W, Wilson SA: Mechanisms for the effects of acetylcholine on sodium 
transport in frog skin . ]  Membr BioI 59:65-75, 198 1 
Didier M, Berman SA, Lindstrom J, Bursztajn S: Characterization of nicotinic 
acetylcholine receptors expressed in primary cultures of cerebellar granule cells. 
Brain Res Mol Brain Res 30:17-28, 1 995 
Drugan A, Vadas A,  Sujov P, Gershoni-Baruch R: Markedly elevated alpha-fetopro­
tein and positive acetylcholinesterase in amniotic fluid from a pregnancy affected 
with dystrophic epidermolysis bullosa. Fetal Diagn Ther 10:37- 40 , 1 995 
Elgoyhen AB, Johnson DS, Boulter J, Vetter DE, Heinemann S: a9: an acetylcholine 
receptor with novel pharmacological properties expressed in rat cochlear hair 
cells. Cell 79:705-7 1 5 ,  1994 
Fairley JA: Calcium: a second messenger. Ad" Dermatol 4:95-1 1 0 , 1 989 
Fieber LA, Adams OJ: Acetylcholine-evoked currents in cultured neurons dissociated 
from rat parasympathetic cardiac ganglia. ]  Physiol (Land) 434:21 5-237, 1 991 
Flores CM, Rogers SW, Pabreza LA, Wolfe BB, Kellar KJ: A subtype of nicotinic 
cholinergic receptor in rat brain is composed of 0:4 and (32 subunits and is 
up-regulated by chronic nicotine treatment. Mol PhannacoI 4 1 :3 1-37, 1 992 
Galzi J-L, Revah F, Bessis A,  Changeux J-P: Functional architecture of the nicotinic 
acetylcholine receptor: from electric organ to brain. Annu Rev Pharmacal Toxicol 
3 1 :37-72, 1991 
Gasic GP, Heinemann S:  Determinants of the calcium permeation of ligand-gated 
cation channels. Curr Opin Cell Bioi 4:670- 677, 1992 
Gilon P, Nenquin M, Henquin JC: Muscarinic stimulation exerts both stimulatory and 
inhibitory effects on the concentration of cytoplasmic Ca2+ in the electrically 
excitable pancreatic B-cell. Biochem ] 3 1 1  :259 -267, 1995 
Grando SA, Crosby AM, Zelickson BD, Dahl MV: Agarose gel keratinocyte out­
growth system as a model of skin re-epithelization: requirement of endogenous 
acetylcholine for outgrowth initiation. ] Invest Dermatol 1 0 1 :804 - 8 1O,  1993a 
Grando SA, Dahl MV: Activation of keratinocyte muscarinic acetylcholine receptors 
reverses pemphigus acantholysis. ]  EliI' Acad Dermatol Venereal 2:72-86, 1993 
Grando SA, Horton RM: The keratinocyte cholinergic system: Acetylcholine as an 
epidermal cytotransmitter. Cllrr Opin Dermatol 4:262-268, 1997 
Grando SA, Horton RM, Pereira EFR, Diethelm-Okita BM, George PM, Albuquer­
que EX, Conti-Fine EM: A nicotinic acetylcholine receptor regulating cell 
adhesion and motility is expressed in human keratinocytes. ) Inl'est Dermatol 
1 05 :774 -781 , 1 995a 
Grando SA, Kist DA, Qi M, Dahl MV: Human keratinocytes synthesize, secrete, and 
degrade acetylcholine. ]  Invest Dermatol 1 0 1  :32-36, 1 993b 
Grando SA,  Horton RM, Mauro TM, Kist DA, Lee TX, Dahl MV : Activation of 
keratinocyte nicotinic cholinergic receptors stimulates calcium influx and en­
hances cell differentiation. ] InIJest DermatoI 1 07 : 4 1 2- 4 1 8 ,  1996 
Grando SA, Zelickson BD, Kist DA, Weinshenker D, Bigliardi PL, Wendelschafer­
Crabb G, Kennedy WR, Dahl MV: Keratinocyte muscarinic acetylcholine 
receptors: immunolocalization and partial characterization. ) Invest Dermatol 
104:95-100, 1 995b 
Haubrich DR: Choline acetyltransferase and its inhibitors. In: Goldber AM, Hanin I 
(eds.). Biology of Cholinergic Function. Raven Press, New York, 1976, pp 239-268 
Hootman SR, Picado-Leonard TM, Burnham DB: Muscarinic acetylcholine receptor 
structure in acinar cells of manunalian exocrine glands. ) Bioi Chem 260:4186-
4194, 1985 
Huhne EC: Muscarinic acetylcholine receptors: typical G-coupled receptors. Symp Soc 
Exp BioI 44:39 -54, 1990 
Hutchins JB, Hollyfield JG: Human retinas synthesize and release acetylcholine. 
] Neurochem 47:81-87, 1986 
Iyengar B:  Modulation of melanocytic activity by acetylcholine. Acta Anat (Basel) 
3 6 : 1 3 9 -1 4 1 ,  1989 
Johansson O. Wang L: Choline acetyltransferase-like immunofluorescence in epider­
mis of human skin. Neurobiology 1 :201-206, 1 993 
Jones SVP: Muscarinic receptor subtypes: modulation of ion channels. Lije Sci 
52:457-464, 1993 
Kohn EC, Alessandro R, Probst J, Jacobs W, Brilley E, Felder CC: Identiflcation and 
molecular characterization of a mS muscarinic receptor in A2058 human 
melanoma cells. Coupling to inhibition of adenylyl cyclase and stimulation of 
phospholipase A2. ] Bioi Chem 27 1 : 1 7476-1 7484 , 1 996 
Lapied B,  Le Corrol1c H ,  Hue B:  Sensitive nicotinic and mixed nicotinic-muscarinic 
receptors in insect neurosecretory cells. Brain Res 533:1 32-136, 1990 
Lisa TA, Casale CH, Domenech CE: Cholinesterase, acid phosphatase, and phospho­
lipase C of Pseudomonas aeruginosa under hyperosmotic conditions in a high­
phosphate medium. Cun- Microbial 28:71-76, 1 994 
McLeskey SW, Wojcik WJ: IdentifIcation of muscarinic receptor subtypes present in 
cerebellar granule cells: prevention of [3HJpropylbenzilyl choline mustard bind­
ing with specifIC antagonists. Neuropharmacol 29:861-868, 1990 
Menon GK, Elias PM, Lee SH, Feingold KR: Localization of calcium in murine 
epidermis following disruption and repair of the penneability barrier. Cell Tissue 
Res 270:503-5 12, 1 992 
Menon GK, Elias PM, Feingold KR: Integrity of the permeability barrier is crucial for 
maintenance of the epidermal calcium gradient. Br] Dennatol 130: 1 3 9 -147, 1994 
Mulle C, Choquet D, Kurn H, Changeux JP: Calcium influx through nicotinic 
48 GRANDO 
receptor in fat central neurons: its relevance to cellular regulation. Nelfnm 
8 : 1 3 5- 1 43 , 1 9 9 2  
Perchellet J - p ,  Kishore GS,  Conrad E A ,  Boutwell RK: Elfects of cell surface 
receptor-altering agents on the binding and biological activity of 1 2-0-tetrade­
canoyphorbol-1 3-accrate in isolated epidermal cells . CarcillOgencsis 3 : 1 1 4 9 - 1 1 5 8 .  
1 9 8 2  
Pumplin D W ,  Bloch RJ : Clathrin-coated membrane: a distinct membrane domain in 
acetylcholine receptor clusters of rat myotubes. Cell J\JIotil Cytoskeletoll 1 5 : 1 2 1 -
1 3 4 ,  1 9 9 0  
Raposo G ,  Dunia I ,  Marullo S ,  Andre C.  Guillet J-G, Strosberg A D ,  Benedett EL. 
Hoebeke J: Redistribution of muscarinic acetylcholine receptors on human 
fibroblasts induced by regulatory ligands. Bioi Cell 60 : 1 1 7- 1 24 ,  1 9 87 
Richman DP,  Arnnson BGW: Nicotinic acetylcholine receptor: evidence for a 
functionally distinct receptor on human lymphocytes .  Proe Nail Acad Sci USA 
7 6 : 4 6 3 2- 4 6 3 5 ,  1 9 7 9  
Sastry B V ,  J anson VE, Cha turvedi AK: Inhibition of human spenn motility by 
inhibitors of choline acetyltransferase . } PllnrH/acol Exp Ther 2 1 6 : 3 7 8 -3 8 4 ,  1 9 8 1  
Scott A:  Acetylcholine i n  nonnal and diseased skin. Br} DcrH/atoI 7 4 : 3 1 7-3 22, 1 9 6 2  
Seidman S ,  Sternfeld M, Ben Aziz-Aloya R, Timberg R, Kaufer-Nachum D .  Soreq H: 
Synaptic and epidermal accumulations of human ace tylcholinesterase are en­
coded by alternative 3 ' -terminal exons. idol Cell Bioi 1 5 : 2993-3 0 0 2 ,  1 9 9 5  
Sharpe GR, Fisher C, Gillespie JI ,  Greenwell J R :  Growth and dilferentiation stimuli 
induce different and distinct increases in intracellular rree calcium in human 
keratinocytes .  Arch Denna!ol Res 284 : 4 4 5- 4 5 0 ,  1 9 93 
Sherwin MA. Gastwirth CM: De trimental effects of cigarette smoking on lower 
extremity wound healing. } Foot StI�� 2 9 : 8 4 - 8 7 , 1 9 90 
Shirvan MH, Pollard HB, Heldman E: Mixed nicotinic and muscarinic features of 
cholinergic receptor coupled to secretion in bovine chromaffin cells. Proc Natl 
Acad Sci USA 8 8 : 4 8 6 0 - 4 8 6 4 .  1 9 9 1  
Silinsky EM: The biophysical pharmacology o f  calcium-dependent acetylcholine 
secretion.  Phanllacol ReI' 3 7 : 8 1 -1 3 2 .  1 9 8 5  
Silverstein P :  Smoking a n d  wound healing. A lii } Me.! 9 3 : 22 S-24S. 1 9 9 2  
J I D  SYMPOSIUM PROCEEDINGS 
S tewart TA, Forrester IT: Identification of a cholinergic receptor in ram spermatozoa. 
Bioi Reprod 1 9 : 9 65-9 7 0 ,  1 9 78 
Takahashi T ,  Tsunoda Y,  Lu Y,  Wiley J ,  Owyang C :  Nicotinic receptor-evoked 
release of acetylcholine and somatostatin in the myenteric plexus is coupled to 
calcium influx via N-type calcium channels . }  Phatlllacol Exp Ther 2 63 : 1 -5 , 1 992 
Theilig C ,  Bernd A ,  Ramirez-Bosca A,  Gormar FF.  Bereiter-Hahnm J ,  Keller­
Stanislawski n, Sewell A C ,  Rietbrock N, Holzmann H: Reactions of human 
keratinocytes ill l'itro a fter application of nicotine. Skin Pharmacol 7 : 3 07-3 1 5 ,  
1 9 9 4  
Thomas P,  Stephens M, Wilkie G,  Amar M,  Lunt  GG, Whiting P, Gallagher T, Pereira 
E,  Alkondon M, Albuquerque EX, Wonnacott S: ( + ) -Anatoxin-a is a potent 
agonist at  neuronal nicotinic acetylcholine recep tors . ]  Nellroc/zem 6 0 : 23 0 8 -23 1 1 ,  
1 9 93 
Tomera JF,  Lilford K: CO-luodulation between acetylcholinesterase and cyclic nucle­
otide signal transduction systems in burn trauma. ,A1etllOds Fil1d Exp elin Pharmaco! 
1 7 : 8 9 -1 0 5 , 1 9 9 5  
U m e z u  Y ,  Nagata N ,  Doi Y ,  Furukawa H, Sagar. T, Hayashida T, Ogata H ,  Fujimoto 
S: Cytochemical and immunocytochemical demonstra tion of acetylcholinesterase 
of the prenatal rat lower Iinlb. Arcll Histol C)'tol 5 6 : 2 1 7-224,  1 9 93 
Williams CL, Hayes VY, Hummel AM, Tarara JE, Halsey TJ : Regulation of 
E-cadherin-mediated adhesion by n1uscarinic acetylcholine receptors in small cell 
lung carcinoma. ) Cell Bioi 1 2 1 : 643- 6 5 4 .  1 9 93 
Williams CL, Lennon VA: Activation of muscarinic acetylcholine receptors inhibits 
cell cycle progression in small cell l ullg carcinoma . Mol Bioi Cell 2 : 3 7 3-3 82. 1 9 9 1  
Westerman RA, Carr R W ,  D elaney C A ,  Morris MJ . Roberts R G :  T h e  role of skin 
nociceptive afferent nerves in blister healing. eli" E).]J Nell1·of 3 0 : 3 9 - 60 ,  1 9 93 
Young RJ. Laing ]C:  The binding ch'lracteristics of cholinergic sites in rabbit 
spermatozoa. Mol Reprod De,' 2 8 : 5 5- 6 1 , 1 99 1  
Yuspa S H ,  Hennings 1-1 .  Tucker R W ,  Jaken S ,  Kilkenny AE, Roop DR: Signal 
transduction for proliferation and differentiation in keratinocytes .  Alln NY Acad 
Sci 5 4 8 : 1 9 1- 1 9 6 , 1 9 8 8  
